Stay updated on Taletrectinib ROS1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Taletrectinib ROS1+ NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page changes remove the old recruitment status and date (Recruiting, 2024-11-21) and replace them with an updated recruitment status (Active, not recruiting) and updated date stamps (2025-10-16 and 2025-10-14) along with expanded section headers. Interpreting this, the study is currently active but not recruiting participants, and there are new or reorganized sections for study headers and contacts.
    Difference
    4%
    Check dated 2025-10-20T12:57:25.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    12%
    Check dated 2025-10-06T04:35:34.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now shows revision v3.1.0, replacing v3.0.2.
    Difference
    0.3%
    Check dated 2025-09-29T01:27:03.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Updated from v3.0.1 to v3.0.2, indicating a new release, and removed the 'Back to Top' link — a minor UI cleanup with no other substantive content changes.
    Difference
    0.7%
    Check dated 2025-09-14T18:46:54.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.7%
    Check dated 2025-09-07T13:07:45.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.
    Difference
    16%
    Check dated 2025-08-31T05:39:06.000Z thumbnail image

Stay in the know with updates to Taletrectinib ROS1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.